• Publications
  • Influence
The second European evidence-based Consensus on the diagnosis and management of Crohn's disease: Special situations.
Principal changes with respect to the 2004 ECCO guidelines Ileocolonoscopy is recommended within the first year after surgery where treatment decisions may be affected (Statement 8C). ThiopurinesExpand
Saccharomyces boulardii in Maintenance Treatment of Crohn’s Disease
The possible role of Saccharomyces boulardii, a nonpathogenic yeast with beneficial effects on the human intestine, in the maintenance treatment of Crohn’s disease has been evaluated. Thirty-twoExpand
Celecoxib versus diclofenac in long-term management of rheumatoid arthritis: randomised double-blind comparison
BACKGROUND Non-steroidal anti-inflammatory drugs (NSAIDs) inhibit cyclo-oxygenase (COX), which leads to suppression of COX-1-mediated production of gastrointestinal-protective prostaglandins.Expand
Effects of ethanol on the gastric mucosa.
Target-controlled propofol infusion during monitored anesthesia in patients undergoing ERCP.
BACKGROUND A target-controlled infusion system automatically adjusts the rate of infusion of propofol to maintain a desired (target) concentration. The aim of this study was to determine whetherExpand
A pilot trial of Saccharomyces boulardii in ulcerative colitis
Objectives Probiotics can be useful in the treatment of inflammatory bowel disease. In a previous report, the non-pathogenic yeast Saccharomyces boulardii was found to be beneficial in theExpand
Recommendations for Probiotic Use--2015 Update: Proceedings and Consensus Opinion.
This paper describes the consensus opinion of the participants in the 4th Triennial Yale/Harvard Workshop on Probiotic Recommendations. The recommendations update those of the first 3 meetings thatExpand
Sedation and monitoring for gastrointestinal endoscopy: A nationwide web survey in Italy.
BACKGROUND Best strategy of sedation/analgesia in gastrointestinal (GI) endoscopy is still debated. AIMS OF THE STUDY To evaluate sedation and monitoring practice among Italian gastroenterologistsExpand
Nicotine treatment for ulcerative colitis.
  • M. Guslandi
  • Medicine
  • British journal of clinical pharmacology
  • 24 December 2001
Ulcerative colitis and Crohn’s disease are chronic inflammatory bowel diseases of unknown aetiology which, although similar in various aspects, exhibit some contrasting features. A typical example isExpand
Outcome of ulcerative colitis after treatment with transdermal nicotine
Objective Transdermal nicotine appears to be of benefit in the short-term treatment of patients with ulcerative colitis. The aim of this study was to determine its long-term effects. Design AExpand